Filing Details

Accession Number:
0000899243-21-046418
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-01 16:42:58
Reporting Period:
2021-11-29
Accepted Time:
2021-12-01 16:42:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1832415 Better Therapeutics Inc. BTTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1807550 J. Andrew Armanino C/O Better Therapeutics, Inc.
548 Market Street, #49404
San Francisco CA 94104
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-29 17,000 $6.96 65,328 No 4 P Indirect By Armanino Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Armanino Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13,334 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.93 to $6.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. Reflects the correction of an immaterial error in Column 5 reported in the Reporting Person's Form 4 filed on November 1, 2021.
  3. These shares are owned directly by the Andrew J. Armanino III and Denise M. Armanino Family Trust (the "Armanino Trust"), and indirectly by the Reporting Person and his spouse, Denise M. Armanino, as trustees of the Armanino Trust.